MedTrace Logo

Promise Women Project

NCT05862844 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-11-07

Study results available
· View outcomes & findings →

Summary

The goal of this study is to develop and test an intervention program to improve cervical cancer prevention among Muslim American women. The main questions the investigators aim to answer are:

* Will the religiously tailored and culturally appropriate intervention program improve participants' knowledge and acceptance of cervical cancer prevention?
* Is the intervention program feasible to conduct and acceptable to participants?

Participants will be asked to:

* Attend focus group sessions to provide input on the development of educational materials.
* Complete pre- and post-intervention surveys to measure changes in knowledge and acceptance of cervical cancer prevention.
* Engage in the intervention program, which includes education and experiential practice/communication skills training.
* Provide feedback through satisfaction surveys. Researchers will compare participant outcomes before and after the intervention to assess its effectiveness. Additionally, the program's feasibility and acceptability will be evaluated based on enrollment rates, successful implementation, participant engagement, retention, and satisfaction.

Conditions

Interventions

BEHAVIORAL

Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia )

The Intervention Arm involves a 90-minute educational session tailored to Muslim women. They will learn about HPV infection risks, cervical cancer risks, and benefits of early screening and HPV vaccination. Discussions cover transmission, consequences, risk factors (behaviors, infections, family history), and importance of early detection. The session provides information on screening methods, check-ups, and HPV vaccine safety. Participants actively engage in discussions, ask questions, and share thoughts. The session empowers women with knowledge to make informed decisions about their health, promoting cervical cancer prevention.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Virginia Commonwealth University

    collaborator OTHER

  • Mark Dignan, PhD

    lead OTHER

Principal Investigators

  • Vanessa L Sheppard, PhD · Virginia Commonwealth University

  • Mark B Dignan, PhD, MPH · University of Kentucky

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2023-10-15
Completion
2023-10-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862844 on ClinicalTrials.gov